Trade Summary

3 days ago, Ra Capital Management, L.P., serving as Dir, 10% owner at Hemab Therapeutics Holdings, Inc. (COAG), purchased 2,840,429 shares at $18.39 per share, for a total transaction value of $52,222,946.00. Following this transaction, Ra Capital Management, L.P. now holds 6,314,525 shares of COAG.

This purchase represents a 82.00% increase in Ra Capital Management, L.P.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, May 4, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, May 6, 2026, 2 days after the trade was made.

Hemab Therapeutics Holdings, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.